Valeo Pharma Inc.
VPHIF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.87K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $9,866.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.32 |
| Beta | 0.81 |
| Outstanding Shares | 98,675,427 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
September 30, 2026
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
$2.73 M
Consensus analyst estimateNext Earnings Call
Expected Date
December 30, 2026
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
$2.73 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Valeo Pharma Inc.
70 employees
CEO: Kyle Steiger
Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to sourcing, licensing, and selling a variety of medicinal products, with a primary emphasis on respiratory, specialized, and hospital-grade generic drugs. Its exten...